These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6677978)

  • 41. Transient weakness and compound muscle action potential decrement in myotonia congenita.
    Deymeer F; Cakirkaya S; Serdaroğlu P; Schleithoff L; Lehmann-Horn F; Rüdel R; Ozdemir C
    Muscle Nerve; 1998 Oct; 21(10):1334-7. PubMed ID: 9736066
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The antimyotonic effect of lamotrigine in non-dystrophic myotonias: a double-blind randomized study.
    Andersen G; Hedermann G; Witting N; Duno M; Andersen H; Vissing J
    Brain; 2017 Sep; 140(9):2295-2305. PubMed ID: 29050397
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sodium channel slow inactivation as a therapeutic target for myotonia congenita.
    Novak KR; Norman J; Mitchell JR; Pinter MJ; Rich MM
    Ann Neurol; 2015 Feb; 77(2):320-32. PubMed ID: 25515836
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effective treatment of paramyotonia congenita by mexiletene].
    Nezu A; Yamashita S; Miyake S; Hayashi M; Iwamoto H
    No To Hattatsu; 1986 May; 18(3):236-7. PubMed ID: 3707771
    [No Abstract]   [Full Text] [Related]  

  • 45. Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy.
    Logigian EL; Ciafaloni E; Quinn LC; Dilek N; Pandya S; Moxley RT; Thornton CA
    Muscle Nerve; 2007 Apr; 35(4):479-85. PubMed ID: 17230537
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Weakness in myotonic syndromes.
    Wiles CM; Edwards RH
    Lancet; 1977 Sep; 2(8038):598-601. PubMed ID: 71410
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Therapy of myotonia congenita].
    Rossi B; Sartucci F; Siciliano G
    Minerva Pediatr; 1986 Aug; 38(15-16):673-8. PubMed ID: 3796521
    [No Abstract]   [Full Text] [Related]  

  • 48. Electrophysiological evaluation of congenital myotonia.
    Rossi B; Siciliano G; Sartucci F
    Electromyogr Clin Neurophysiol; 1985; 25(6):413-22. PubMed ID: 4065028
    [No Abstract]   [Full Text] [Related]  

  • 49. Propagation disturbance of motor unit action potentials during transient paresis in generalized myotonia: a high-density surface EMG study.
    Drost G; Blok JH; Stegeman DF; van Dijk JP; van Engelen BG; Zwarts MJ
    Brain; 2001 Feb; 124(Pt 2):352-60. PubMed ID: 11157562
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Myotonia congenita with painful muscle cramps.
    Sunohara N; Tomi H; Nakamura A; Arahata K; Nonaka I
    Intern Med; 1996 Jun; 35(6):507-11. PubMed ID: 8835606
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Muscle Na+ channelopathies: MRI detects intracellular 23Na accumulation during episodic weakness.
    Weber MA; Nielles-Vallespin S; Essig M; Jurkat-Rott K; Kauczor HU; Lehmann-Horn F
    Neurology; 2006 Oct; 67(7):1151-8. PubMed ID: 16931510
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Myotonia and muscular weakness corrected by exercise--clinical and EMG study apropos of a case].
    Ruh D; Warter JM; Marescaux C; Malibary H; Jesel M
    Rev Electroencephalogr Neurophysiol Clin; 1982 Aug; 12(2):140-6. PubMed ID: 7134580
    [No Abstract]   [Full Text] [Related]  

  • 53. Calixmexitil: Calixarene-based Cluster of Mexiletine with Amplified Anti-myotonic Activity as A Novel Use-dependent Sodium Channel Blocker.
    Delnavaz Shahr A; Nasuhi Pur F
    Iran J Pharm Res; 2019; 18(3):1351-1357. PubMed ID: 32641945
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Neuromuscular diseases as a cause of neonatal respiratory insufficiency].
    Dinger J; Lorenz P
    Monatsschr Kinderheilkd; 1991 Oct; 139(10):692-4. PubMed ID: 1961209
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and safety of mexiletine in non-dystrophic myotonias: A randomised, double-blind, placebo-controlled, cross-over study.
    Vicart S; Franques J; Bouhour F; Magot A; Péréon Y; Sacconi S; Nadaj-Pakleza A; Behin A; Zahr N; Hézode M; Fournier E; Payan C; Lacomblez L; Fontaine B
    Neuromuscul Disord; 2021 Nov; 31(11):1124-1135. PubMed ID: 34702654
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Muscle weakness or rigidity due to hereditary ion channel diseases].
    Links TP; van der Hoeven JH
    Ned Tijdschr Geneeskd; 2001 Feb; 145(6):249-51. PubMed ID: 11236369
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Temperature-sensitive repetitive discharges in paramyotonia congenita.
    Weiss MD; Mayer RF
    Muscle Nerve; 1997 Feb; 20(2):195-7. PubMed ID: 9040658
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phenotypic variability in myotonia congenita.
    Colding-Jørgensen E
    Muscle Nerve; 2005 Jul; 32(1):19-34. PubMed ID: 15786415
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and in vitro sodium channel blocking activity evaluation of novel homochiral mexiletine analogs.
    Carocci A; Catalano A; Bruno C; Lentini G; Franchini C; De Bellis M; De Luca A; Conte Camerino D
    Chirality; 2010 Mar; 22(3):299-307. PubMed ID: 19544349
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Electromyographic features of 3 forms of myotonia].
    Luk'ianov MV; Chuchin MIu
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(11):37-44. PubMed ID: 7180301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.